Series A - Clearside Biomedical

Series A - Clearside Biomedical

Investment Firm

Overview

Clearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products.

Announced Date

Feb 12, 2013

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Santen Pharmaceutical

Santen Pharmaceutical

No designation

Participant Investors

3

Investor Name
Participant InvestorSanten Pharmaceutical
Participant InvestorGRA Venture Fund
Participant InvestorHatteras Venture Partners

Round Details and Background

Clearside Biomedical raised $7899987 on 2013-02-12 in Series A

Clearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products.

Company Funding History

8

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 02, 2014
Series B - Clearside Biomedical
5-16.0M
May 12, 2014
Venture Round - Clearside Biomedical
-6.0M
Feb 12, 2013
Series A - Clearside Biomedical
3-7.9M
Jan 05, 2012
Series A - Clearside Biomedical
2-4.0M

Recent Activity

There is no recent news or activity for this profile.